Stromagen

Source: Wikipedia, the free encyclopedia.

Stromagen is a product that is made of

autologous expanded mesenchymal stem cells OTI-010.[1][2] Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. It is not yet known whether Stromagen improves the success of stem cell transplantation in women with breast cancer.[3]

References

  1. ^ "NCI Dictionary of Cancer Terms". National Cancer Institute.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ "Glossary - Maryland Oncology". marylandoncology.com.
  3. ^ "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017.Public Domain This article incorporates text from this source, which is in the public domain.
drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Stromagen&oldid=1189186362"